Yardena Samuels

17PUBLICATIONS
112CO-AUTHORS
Molecular targetsInnate immunityTumour immunologyMedical infection agents (incl. prions)Nanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 07, 2025
Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer.

Nofar Gumpert, Shira Sagie, Claudia Arnedo-Pac

|Dec 23, 2024
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma.

Sapir Cohen Shvefel, Joy A Pai, Yingying Cao

|Jul 06, 2023
The landscape of T cell antigens for cancer immunotherapy.

Aviyah Peri, Nadja Salomon, Yochai Wolf

|Jun 28, 2023
Neoantigens in cancer immunotherapy: quantity vs. quality.

Yochai Wolf, Yardena Sameuls

|May 22, 2023
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC.

Aaron Javitt, Merav D Shmueli, Matthias P Kramer

|Apr 05, 2022
Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally.

Yochai Wolf, Yardena Samuels

Pageof 3

Frequent Collaborators

3 joint publications

Yochai Wolf

3 joint publications

Shifra Ben-Dor

3 joint publications

Elizabeta Yakubovich

3 joint publications

Charles Swanton